Roivant Sciences Ltd ROIV:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 9:50 AM EDT
4.12quote price arrow up+0.06 (+1.35%)
Volume
71,897
52 week range
2.52 - 16.76
Loading...
  • Open4.05
  • Day High4.12
  • Day Low3.96
  • Prev Close4.06
  • 52 Week High16.76
  • 52 Week High Date12/20/21
  • 52 Week Low2.52
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap2.899B
  • Shares Out704.38M
  • 10 Day Average Volume0.83M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-60.62

KEY STATS

  • Open4.05
  • Day High4.12
  • Day Low3.96
  • Prev Close4.06
  • 52 Week High16.76
  • 52 Week High Date12/20/21
  • 52 Week Low2.52
  • 52 Week Low Date05/12/22
  • Market Cap2.899B
  • Shares Out704.38M
  • 10 Day Average Volume0.83M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-60.62

RATIOS/PROFITABILITY

  • EPS (TTM)-1.60
  • P/E (TTM)-2.57
  • Fwd P/E (NTM)-2.52
  • EBITDA (TTM)-1.479B
  • ROE (TTM)-70.47%
  • Revenue (TTM)51.87M
  • Gross Margin (TTM)80.82%
  • Net Margin (TTM)-2,268.79%
  • Debt To Equity (MRQ)30.13%

EVENTS

  • Earnings Date11/15/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Roivant Sciences Ltd

 

Profile

MORE
Roivant Sciences Ltd. is a pharma company. The Company is focused on developing transformative medicines that address areas of unmet medical need. The Company, through its subsidiaries, is focused on delivering medicines and technologies to patients. The Company builds biotech and healthcare technology companies (Vants) and deploys technology to drive research and development and commercialization. The Company’s product candidate includes VTAMA (tapinarof), IMVT-1401...
Vivek Ramaswamy J.D.
Executive Chairman of the Board, Founder
Matthew Gline
Chief Executive Officer, Director
Eric Venker M.D.
President, Chief Operating Officer
Mayukh Sukhatme M.D.
President, Chief Investment Officer
Richard Pulik
Chief Financial Officer
Rakhi Kumar CPA
Chief Accounting Officer
Address
Clarendon House, 2 Church Street
Hamilton
HM11
Bermuda

Top Peers

SYMBOLLASTCHG%CHG
XENE
Xenon Pharmaceuticals Inc
37.26+0.13+0.34%
FATE
Fate Therapeutics Inc
23.39-0.17-0.72%
SAGE
SAGE Therapeutics Inc
41.73+0.36+0.87%
RXDX
Prometheus Biosciences Inc
60.13+0.65+1.09%
ARVN
Arvinas Inc
45.00+0.22+0.49%